IDEXX Laboratories Executives Engage in Significant Stock Transactions
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Lane Michael | Executive Vice President | Sell | $5,279,893 | Form 4 |
| Mazelsky Jonathan Jay | President and CEO | Sell | $18,491,642 | Form 4 |
| Hunt Nimrata | Executive Vice President | Sell | $4,503,163 | Form 4 |
Michael Lane, Executive Vice President of IDEXX Laboratories, sold 8,411 shares of common stock on August 6, 2025, at weighted average prices between $627.5634 and $628.8866, totaling $5,279,893. Post-transaction, Lane's direct ownership stands at 7,131 shares, with an additional 592 shares held indirectly through his spouse.
Jonathan Jay Mazelsky, President and CEO of IDEXX Laboratories, executed the sale of 29,260 shares on August 6, 2025, with weighted average prices ranging from $626.9024 to $639.3718, resulting in a total of $18,491,642. Following the sales, Mazelsky directly owns 83,311 shares.
Hunt Nimrata, Executive Vice President of IDEXX Laboratories, sold 7,143 shares on August 6, 2025, at prices between $629.865 and $630.9087 per share, for a total of $4,503,163. Nimrata's direct ownership after the sales is 18,006 shares, with an additional 160 shares held indirectly with a spouse.